Impact on the Quality of Erections after Completing a Low-Intensity Extracorporeal Shock Wave Treatment Cycle on a Group of 710 Patients

Héctor A Corredor Ayala, José Pablo Saffon Cuartas, Diana Cerquera Cleves, Héctor A Corredor Ayala, José Pablo Saffon Cuartas, Diana Cerquera Cleves

Abstract

Objective: The aim of this study is to evaluate the response to low-intensity extracorporeal shock wave therapy in a group of patients with organic vascular erectile dysfunction.

Materials and methods: This is an observational retrospective study. The researchers reviewed 710 patients with a clinical diagnosis of organic vascular erectile dysfunction (ED) of more than 3-month duration from male sexual health clinics of the Boston Medical Group from 12 cities in Spain and 4 in Mexico. Patients received 5 outpatient shock wave therapy sessions. They were evaluated with the erection hardness score (EHS) before the first session (n = 710), at the end of the last session (n = 710), and one month after the last session (n = 412).

Results: In the first examination, the EHS improved in 43.1% (306/710) of subjects compared to the baseline measurement and ability to penetrate increased from 26.8% to 44% (p < 0.0001). In the second examination, the ability to penetrate was 37.9%, lower than in the first (p=0.042) but higher than the baseline (p=0.0001).

Conclusions: The results suggest that the shock wave therapy with or without concomitant treatments improved the quality of erections in patients with erectile dysfunction treated in specialised male sexual health clinics. This trial is registered with NCT03237143.

Figures

Figure 1
Figure 1
EHS progression during follow-up.

References

    1. Gratzke C., Angulo J., Chitaley K., et al. Anatomy, physiology, and pathophysiology of erectile dysfunction. Journal of Sexual Medicine. 2010;7(1):445–475. doi: 10.1111/j.1743-6109.2009.01624.x.
    1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. Journal of the American Medical Association. 1993;270(1):83–90. doi: 10.1001/jama.1993.03510010089036.
    1. Feldman H. A., Goldstein I., Hatzichristou D. G., Krane R. J., McKinlay J. B. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. Journal of Urology. 1994;151(1):54–61. doi: 10.1016/s0022-5347(17)34871-1.
    1. Braun M., Wassmer G., Klotz T., Reifenrath B., Mathers M., Engelmann U. Epidemiology of erectile dysfunction: results of the “Cologne Male Survey”. International Journal of Impotence Research. 2000;12(6):305–311. doi: 10.1038/sj.ijir.3900622.
    1. Salonia A., Castagna G., Saccà A., et al. Is erectile dysfunction a reliable proxy of general male health status? The case for the International Index of Erectile Function-Erectile Function domain. Journal of Sexual Medicine. 2012;9(10):2708–2715. doi: 10.1111/j.1743-6109.2012.02869.x.
    1. Moyad M. A., Barada J. H., Lue T. F., Mulhall J. P., Goldstein I., Fawzy A. Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part I. Urologic Clinics of North America. 2004;31(2):249–257. doi: 10.1016/j.ucl.2004.01.006.
    1. Dong J.-Y., Zhang Y.-H., Qin L.-Q. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. Journal of the American College of Cardiology. 2011;58(13):1378–1385. doi: 10.1016/j.jacc.2011.06.024.
    1. Gupta B. P., Murad M. H., Clifton M. M., Prokop L., Nehra A., Kopecky S. L. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Archives of Internal Medicine. 2011;171(20):1797–1803. doi: 10.1001/archinternmed.2011.440.
    1. Gandaglia G., Briganti A., Jackson G., et al. A systematic review of the association between erectile dysfunction and cardiovascular disease. European Urology. 2014;65(5):968–978. doi: 10.1016/j.eururo.2013.08.023.
    1. Hatzimouratidis K., Amar E., Eardley I., et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. European Urology. 2010;57(5):804–814. doi: 10.1016/j.eururo.2010.02.020.
    1. Eardley I., Donatucci C., Corbin J., et al. Pharmacotherapy for erectile dysfunction. Journal of Sexual Medicine. 2010;7(1):524–540. doi: 10.1111/j.1743-6109.2009.01627.x.
    1. Ciampa A. R., de Prati A. C., Amelio E., et al. Nitric oxide mediates anti-inflammatory action of extracorporeal shock waves. FEBS Letters. 2005;579(30):6839–6845. doi: 10.1016/j.febslet.2005.11.023.
    1. Vardi Y., Appel B., Jacob G., Massarwi O., Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. European Urology. 2010;58(2):243–248. doi: 10.1016/j.eururo.2010.04.004.
    1. Yee C.-H., Chan E. S., Hou S. S.-M., Ng C.-F. Extracorporeal shockwave therapy in the treatment of erectile dysfunction: a prospective, randomized, double-blinded, placebo controlled study. International Journal of Urology. 2014;21(10):1041–1045. doi: 10.1111/iju.12506.
    1. Mittermayr R., Hartinger J., Antonic V., et al. Extracorporeal shock wave therapy (ESWT) minimizes ischemic tissue necrosis irrespective of application time and promotes tissue revascularization by stimulating angiogenesis. Annals of Surgery. 2011;253(5):1024–1032. doi: 10.1097/sla.0b013e3182121d6e.
    1. Mulhall J. P., Goldstein I., Bushmakin A. G., Cappelleri J. C., Hvidsten K. Validation of the erection hardness score. Journal of Sexual Medicine. 2007;4(6):1626–1634. doi: 10.1111/j.1743-6109.2007.00600.x.
    1. Chung E., Cartmill R. Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial. BJU International. 2015;115(5):46–49. doi: 10.1111/bju.13035.
    1. Olsen A. B., Persiani M., Boie S., Hanna M., Lund L. Can low-intensity extracorporeal shockwave therapy improve erectile dysfunction? A prospective, randomized, double-blind, placebo-controlled study. Scandinavian Journal of Urology. 2015;49(4):329–333. doi: 10.3109/21681805.2014.984326.
    1. Wang C.-J., Wang F.-S., Yang K. D. Biological mechanism of musculoskeletal shockwaves. International Society for Musculoeskeletal Shockwave Therapy. ISMST Newsletter. 2006;1:6–11.
    1. Liu J., Zhou F., Li G.-Y., et al. Evaluation of the effect of different doses of low energy shock wave therapy on the erectile function of streptozotocin (STZ)-induced diabetic rats. International Journal of Molecular Sciences. 2013;14(5):10661–10673. doi: 10.3390/ijms140510661.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa